- Home
- KPLT vs ONCY Comparison
KPLT vs ONCY Comparison
Compare KPLT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- ONCY
- Stock Information
- Founded
- KPLT 2012
- ONCY 1998
- Country
- KPLT United States
- ONCY Canada
- Employees
- KPLT N/A
- ONCY N/A
- Industry
- KPLT Diversified Commercial Services
- ONCY Pharmaceuticals and Biotechnology
- Sector
- KPLT Consumer Discretionary
- ONCY Health Care
- Exchange
- KPLT Nasdaq
- ONCY Nasdaq
- Market Cap
- KPLT 79.1M
- ONCY 89.7M
- IPO Year
- KPLT N/A
- ONCY 1999
- Fundamental
- Price
- KPLT $14.66
- ONCY $1.28
- Analyst Decision
- KPLT Hold
- ONCY Strong Buy
- Analyst Count
- KPLT 1
- ONCY 5
- Target Price
- KPLT $10.00
- ONCY $5.00
- AVG Volume (30 Days)
- KPLT 113.2K
- ONCY 1.0M
- Earning Date
- KPLT 11-05-2025
- ONCY 11-11-2025
- Dividend Yield
- KPLT N/A
- ONCY N/A
- EPS Growth
- KPLT N/A
- ONCY N/A
- EPS
- KPLT N/A
- ONCY N/A
- Revenue
- KPLT $267,101,999.00
- ONCY N/A
- Revenue This Year
- KPLT $22.88
- ONCY N/A
- Revenue Next Year
- KPLT $10.98
- ONCY N/A
- P/E Ratio
- KPLT N/A
- ONCY N/A
- Revenue Growth
- KPLT 13.04
- ONCY N/A
- 52 Week Low
- KPLT $5.08
- ONCY $0.33
- 52 Week High
- KPLT $24.34
- ONCY $1.51
- Technical
- Relative Strength Index (RSI)
- KPLT 43.78
- ONCY 53.21
- Support Level
- KPLT $13.18
- ONCY $1.20
- Resistance Level
- KPLT $14.86
- ONCY $1.47
- Average True Range (ATR)
- KPLT 1.64
- ONCY 0.07
- MACD
- KPLT -0.55
- ONCY -0.01
- Stochastic Oscillator
- KPLT 33.04
- ONCY 35.77
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.